GGrantIndex
← Leaderboards

Akiko Shimamura

Dana-Farber Cancer Institute

$14,324,270
Attributed
$36,277,220
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$36,277,220 · 10

By mechanism

R24$13,438,008 · 3
U01$8,256,108 · 1
RC2$6,432,141 · 1
R01$3,748,274 · 1
P01$2,574,544 · 1
RC1$1,000,000 · 1

Top collaborators

Most similar at Dana-Farber Cancer Institute

Same institution · by research overlap

Others in their field

Top investigators on “Molecular

Research focus

MolecularResearch PersonnelGeneticInheritedSyndromePancytopeniaGenesPathway InteractionsCellsBaseMedicalCommunitiesPhenotypeClinical ResearchBostonHematopoiesisMarrowDiagnosisMutationPathogenesisInvestigationClinical PhenotypeCollaborationsResources

Grant awards (51)

Severe Chronic Neutropenia International Registry$1,031,877
R24 · FY2025 · AI · contact PI
Severe Chronic Neutropenia International Registry$62,072
R24 · FY2025 · AI · contact PI
Severe Chronic Neutropenia International Registry$8,276
R24 · FY2025 · AI · contact PI
Severe Chronic Neutropenia International Registry$8,276
R24 · FY2025 · AI · contact PI
Severe Chronic Neutropenia International Registry$1,122,390
R24 · FY2024 · AI · contact PI
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine$1,271,028
RC2 · FY2023 · DK · contact PI
Severe Chronic Neutropenia International Registry$1,131,234
R24 · FY2023 · AI · contact PI
Severe Chronic Neutropenia International Registry$1,345,104
R24 · FY2022 · AI · contact PI
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine$1,271,028
RC2 · FY2022 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,206,728
U01 · FY2022 · HL
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine$1,271,028
RC2 · FY2021 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,223,081
U01 · FY2021 · HL
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine$1,278,845
RC2 · FY2020 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,235,586
U01 · FY2020 · HL
Preclinical Studies of Marrow Failure and Clonal Evolution in Fanconi Anemia$499,509
P01 · FY2020 · HL · contact PI
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine$1,340,212
RC2 · FY2019 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,251,085
U01 · FY2019 · HL
Preclinical Studies of Marrow Failure and Clonal Evolution in Fanconi Anemia$504,134
P01 · FY2019 · HL · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,264,005
U01 · FY2018 · HL
Preclinical Studies of Marrow Failure and Clonal Evolution in Fanconi Anemia$508,646
P01 · FY2018 · HL · contact PI
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes$1,636,056
R24 · FY2017 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,030,943
U01 · FY2017 · HL
Preclinical Studies of Marrow Failure and Clonal Evolution in Fanconi Anemia$515,185
P01 · FY2017 · HL · contact PI
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes$1,636,073
R24 · FY2016 · DK · contact PI
Stem cells for therapeutics discovery in genetic blood disorders$1,044,680
U01 · FY2016 · HL
Preclinical Studies of Marrow Failure and Clonal Evolution in Fanconi Anemia$547,070
P01 · FY2016 · HL · contact PI
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes$1,635,660
R24 · FY2015 · DK · contact PI
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes$1,635,392
R24 · FY2014 · DK · contact PI
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes$1,692,348
R24 · FY2013 · DK · contact PI
Clinical and Molecular Characterization of Familial Marrow Failure Syndrome$493,250
R24 · FY2012 · DK
Shwachman-Diamond Syndrome: Molecular Pathogenesis$435,600
R01 · FY2012 · HL · contact PI
Shwachman-Diamond Syndrome: Molecular Pathogenesis$440,000
R01 · FY2011 · HL · contact PI
Towards a Model of Fanconi Anemia$500,000
RC1 · FY2010 · HL · contact PI
Shwachman-Diamond Syndrome: Molecular Pathogenesis$440,000
R01 · FY2010 · HL · contact PI
Towards a Model of Fanconi Anemia$500,000
RC1 · FY2009 · HL · contact PI
Shwachman-Diamond Syndrome: Molecular Pathogenesis$440,000
R01 · FY2009 · HL · contact PI
Shwachman-Diamond Syndrome: Molecular Pathogenesis$334,706
R01 · FY2009 · HL · contact PI
Shwachman-Diamond Syndrome International Registry and Repository$88,000
R03 · FY2009 · AI · contact PI
Shwachman-Diamond Syndrome: Molecular Pathogenesis$333,759
R01 · FY2008 · HL · contact PI
Shwachman-Diamond Syndrome International Registry and Repository$88,000
R03 · FY2008 · AI · contact PI
Shwachman-Diamond Syndrome: Molecular Pathogenesis$320,485
R01 · FY2007 · HL · contact PI
Clinical Applications of a Novel Fanconi Anemia Assay$130,437
K23 · FY2007 · HL · contact PI
Shwachman-Diamond Syndrome: Molecular Pathogenesis$330,057
R01 · FY2006 · HL · contact PI
Clinical Applications of a Novel Fanconi Anemia Assay$130,437
K23 · FY2006 · HL · contact PI
Shwachman-Diamond Syndrome: Molecular Pathogenesis$337,666
R01 · FY2005 · HL
Clinical Applications of a Novel Fanconi Anemia Assay$84,805
K23 · FY2005 · HL
Shwachman-Diamond Syndrome: Molecular Pathogenesis$336,000
R01 · FY2004 · HL
Clinical Applications of a Novel Fanconi Anemia Assay$45,632
K23 · FY2004 · HL
Shwachman-Diamond Syndrome: Molecular Pathogenesis$1
R01 · FY2004 · HL
Clinical Applications of a Novel Fanconi Anemia Assay$130,437
K23 · FY2003 · HL
Clinical Applications of a Novel Fanconi Anemia Assay$130,397
K23 · FY2002 · HL